A Case of Cardiac Tamponade in Chronic Renal Failure Patient Receiving Minoxidil.
- Author:
Sang Wook KIM
;
Sang Youb HAN
;
Dong Kyu JIN
;
Young Joo KWON
;
Heui Jung PYO
- Publication Type:Case Report
- Keywords:
Minoxidil;
Pericardial dffusion;
Cardiac tamponade;
Chronic renal failure
- MeSH:
Blood Pressure;
Cadaver;
Cardiac Tamponade*;
Cardiomegaly;
Dialysis;
Dyspnea;
Emergency Treatment;
Female;
Furosemide;
Humans;
Hypertension;
Hypertrichosis;
Kidney Failure, Chronic*;
Kidney Transplantation;
Middle Aged;
Minoxidil*;
Pericardial Effusion;
Pericardiocentesis;
Radiography, Thoracic;
Reflex;
Tachycardia;
Tissue Donors
- From:Korean Journal of Nephrology
1998;17(5):823-826
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Minoxidil is a potent direct-acting peripheral vasodilator indicated in the management of severe or refractory hypertension. Well-known adverse effects include reflex tachycardia, fluid retention and hypertrichosis. This drug has also been reported to cause pericardial effusion in about three percent of nondialyzed patients with compromised renal function and to cause cardiac tamponade less frequently. Many studies have reported that the mean duration of therapy that caused pericardial effusion was about 8 months (range 1 month-53 months). We report a case of cardiac tamponade in nondialyzed patient with chronic renal failure receiving minoxidil for 10 years. A 58-year-old female was admitted to our hospital with dyspnea of NYHA III. She was a chronic renal failure patient without dialysis treatment and received kidney transplantation from cadaver donor and was dignosed chronic rejection in 1994. Minoxidil 10mg has been used for past 10 years. Lasix has been used for past 2 years, with dosage of 40mg to 240mg. On admission, blood pressure was 90/60mm Hg. Cardiomegaly was seen on chest radiograph. The two-dimensional echocardiogram showed a large amount of pericardial effusion. Emergency treatment with pericardiocentesis removed 2500ml of straw- colored pericardial fluid and resulted in marked improvement of dyspnea and stabilized blood pressure. The minoxidil was discontinued. The evidence of pericardial effusion was not seen for 12 months after minoxidil had been discontinued.
